Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
2021
Abstract Background For postmenopausal women with hormone-receptor–positive breast cancer, the most effective duration for adjuvant therapy with an aromatase inhibitor remains unclear. Methods In t...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
4
Citations
NaN
KQI